Mednax Inc Stock News

Mednax (MD) purchases Night Lite Pediatrics, LLC in Orlando to enhance its pediatric business line.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2021 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 17, 2022

Mednax (MD) to issue $400M in aggregate principal amount of senior notes due 2030 in a private offering.The proposed offering of notes is subject to market and other conditions.Net

Banking on its strategic measures and a streamlined business, Mednax (MD) holds potential to reap benefits for investors.

High patient volumes, mergers and buyouts, and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH.

MEDNAX, Inc. (NYSE:MD) Jefferies Financial Group issued their Q1 2022 earnings estimates for MEDNAX in a research note issued on Tuesday, December 21st. Jefferies Financial Group analyst B. Tanquilut anticipates that the company will post earnings per share of $0.20 for the quarter. Jefferies Financial Group also issued estimates for MEDNAXs Q2 2022 earnings []

MEDNAX (NYSE:MD) had its target price decreased by Credit Suisse Group from $33.00 to $32.00 in a report released on Wednesday morning, Stock Target Advisor reports. Credit Suisse Group currently has an outperform rating on the stock. MD has been the topic of several other reports. BMO Capital Markets dropped their target price on MEDNAX []

Mednax with ticker code (MD) have now 10 analysts in total covering the stock. The consensus rating is ''Hold''. The target price ranges between 37 and 14 calculating the average target price we see 30.6. With the stocks previous close at 26.64 this would imply there is a potential upside of 14.9%. The 50 day moving average now sits at 26.97 while the 200 day moving average is 28.78. The market cap for the company is $2,324m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="MD" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] MEDNAX, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

First Bank & Trust raised its position in MEDNAX, Inc. (NYSE:MD) by 12.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,192 shares of the companys stock after purchasing an additional 884 shares during the quarter. First Bank & []

Bank of America Corp DE lessened its stake in shares of MEDNAX, Inc. (NYSE:MD) by 4.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 247,885 shares of the companys stock after selling 12,208 shares during the period. Bank of America Corp []

The "AI Medical Imaging" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global AI Medical Imaging Industry presents a market overview, product details,

Wall Street analysts expect MEDNAX, Inc. (NYSE:MD) to post $0.43 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have issued estimates for MEDNAXs earnings, with the lowest EPS estimate coming in at $0.39 and the highest estimate coming in at $0.52. MEDNAX reported earnings per share of $0.25 during []

Parametric Portfolio Associates LLC lowered its position in shares of MEDNAX, Inc. (NYSE:MD) by 10.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 678,555 shares of the companys stock after selling 82,496 shares during the period. Parametric Portfolio Associates []